MASI - マシモ （Masimo Corporation） マシモMASIのチャート
MASIの企業情報
| symbol | MASI |
|---|---|
| 会社名 | Masimo Corp. （マシモ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 マシモ(Masimo Corporation) は医療技術企業であり、非侵襲患者モニタリング製品を開発・製造・販売する。同社の事業はマシモ信号抽出技術（SET）パルスオキシメトリーと知られる測定スルーモーションおよび低灌流パルスオキシメトリーモニタリングである。製品には光学特性、光学臓器酸素濃度測定、電気、脳機能モニタリング、音響呼吸モニタリング、呼気モニタリングなどの血液成分の非侵襲的モニタリングが含まれる。同社はまたRoot患者のモニタリングおよび接続プラットフォーム、Radical-7ベッドサイドとポータブル患者モニタ、Radius-7ウェアラブル無線患者モニタを開発する。同社はPatient SafetyNetリモート患者監視監視システムを提供する。これにより、患者はパーソナルコンピュータベースのモニタまたはポケベル、ボイスオーバーインターネットプロトコル（IP）電話、スマートフォンを通じてケア提供者によって監視される。 マシモは、米国の医療技術企業。非侵襲的患者監視製品を開発、製造、売買に従事する。患者監視ソリュ―ションは、一般的にはモニタ―や回路基板とセンサ―に組み込まれる。主にに直接パ―トナ―代理店もしくは元の機器メ―カ―を通じて、病院、救急医療サ―ビス・プロバイダ―、医師、獣医師、介護施設や消費者に同社製品を販売する。 Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Masimo's mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.4 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,5 improve CCHD screening in newborns,6 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.7-10 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,11 and is the primary pulse oximetry at 9 of the top 10 hospitals according to the 2020-21 U.S. News and World Report Best Hospitals Honor Roll.12 Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET® sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient's physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo's family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView™, UniView :60™, and Masimo SafetyNet™. |
| 本社所在地 | 52 Discovery Irvine CA 92618 USA |
| 代表者氏名 | Joseph E. Kiani ジョセフ・E・キアニ |
| 代表者役職名 | Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者 |
| 電話番号 | +1 949-297-7000 |
| 設立年月日 | 32629 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2007年 |
| 従業員数 | 4600人 |
| url | www.masimo.com |
| nasdaq_url | https://www.nasdaq.com/symbol/masi |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 233.99600 |
| 終値（lastsale） | 119.46 |
| 時価総額（marketcap） | 6232234889.76 |
| 時価総額 | 時価総額（百万ドル） 650.162 |
| 売上高 | 売上高（百万ドル） 843.44700 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 5620.515 |
| 当期純利益 | 当期純利益（百万ドル） 207.08600 |
| 決算概要 | 決算概要 BRIEF: For the 26 weeks ended 30 June 2018 Masimo Corporation revenues increased 9% to $424.6M. Net income decreased 7% to $89.5M. Revenues reflect United States segment increase of 10% to $281.2M Europe Middle East and Africa segment increase of 22% to $78.4M. Net income was offset by Selling general and administrative increase of 7% to $142.6M (expense) Research and development increase of 23% to $37.7M (expense). |
MASIのテクニカル分析
MASIのニュース
Apple, Masimo court case over smartwatch trade secrets ends in hung jury 2023/05/03 14:15:14 FierceBiotech
Apple, Masimo court case over smartwatch trade secrets ends in hung jury apark Wed, 05/03/2023 - 10:15
Apple-Masimo smartwatch trade secrets suit ends in mistrial 2023/05/02 18:01:18 EIN News International Trade
A smartwatch trade secrets battle between Apple and health tech company Masimo ended in a mistrial yesterday when jurors failed to reach an unanimous verdict. Masimo sued Apple in 2020 for allegedly poaching its employees and stealing trade secrets related …
Masimo Corp. mistrial eliminates ''splashy'' near-term catalyst - Raymond James 2023/05/02 15:12:03 Investing.com
https://www.investing.com/news/stock-market-news/masimo-corp-mistrial-eliminates-splashy-nearterm-catalyst--raymond-james-432SI-3070335
Judge declares mistrial in Apple trade secrets case 2023/05/02 14:41:16 Business Journals
A Southern California judge declared a mistrial Monday in the Masimo Corp. trade secret lawsuit against Apple Inc. when the jury failed to reach a unanimous verdict.
Masimo Falls after Mistrial Verdict in AAPL Case 2023/05/02 13:01:42 TipRanks
Shares of Masimo (NASDAQ: MASI) fell in pre-market trading on Tuesday after the medical devices company’s trade secrets fight with tech giant Apple…
Clinical Alarm Management Market Is Booming Worldwide 2023-2030 | Spok Inc., Masimo, GE Healthcare, Medtronic PLC 2023/04/04 11:08:26 EIN News Tech
SEATTLE, WASHINGTON, UNITED STATES, April 4, 2023 /EINPresswire.com/ -- “Coherent Market Insights offers a 45% discount on Clinical Alarm Management Market Reports on Single User Access and Unlimited User Access“ Report Description: The …
Masimo opioid overdose alert system Halo gets FDA De Novo tag 2023/04/03 16:02:17 Seeking Alpha
Masimo (MASI) said the U.S. FDA granted De Novo to Masimo Opioid Halo, an opioid overdose prevention and alert system. Read more here
Masimo Opioid Halo Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System 2023/04/03 12:00:00 Wallstreet:Online
Masimo (NASDAQ: MASI) today announced that Masimo Opioid Halo, an opioid overdose prevention and alert system, has been granted a De Novo by the FDA – making it the first and only FDA-cleared monitoring solution for detecting opioid-induced respiratory depression, the leading cause of death from opioid overdose. With the De Novo, Masimo also becomes the first winner of an FDA Opioid Innovation
Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom Smartwatch 2023/03/28 12:00:00 Wallstreet:Online
Masimo (NASDAQ: MASI), a global leader in pulse oximetry and innovative noninvasive monitoring technologies, unveiled the newest addition to its wearable product line: the Masimo Freedom smartwatch. Developed to revolutionize the wearable technology industry, the Masimo Freedom smartwatch offers you the freedom to take control of your personal health and privacy through accurate and continuous
Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom™ Smartwatch 2023/03/28 12:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo announced Freedom™, a revolutionary wearable that combines accurate, continuous health tracking and breakthrough features.
Casablanca stock exchange: MASI closes down sharply by 3.82 2023/01/05 20:23:30 Hespress English
The Casablanca Stock Exchange closed down sharply on Thursday, with its main index, the MASI, falling by 3.82% to 10,040.91 points (pts). At the end of a session in the red, the MSI 20, index grouping the 20 most liquid stocks, lost 3.72% to 802.67 pts. The post Casablanca stock exchange: MASI closes down sharply by 3.82 appeared first on HESPRESS English - Morocco News .
New Study Finds That Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality 2023/01/05 07:00:17 Financial Post
NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the findings of a before-and-after study published in PLoS ONE in which Dr. Ahmed Balshi and colleagues at King Saud Medical City in Riyadh, Saudi Arabia, evaluated the impact of implementing remote patient monitoring with Masimo Patient SafetyNet™ on the efficacy of hospital rapid response teams (RRTs). […]
New Study Finds That Masimo Patient SafetyNet Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality 2023/01/05 07:00:00 Wallstreet:Online
Masimo (NASDAQ: MASI) today announced the findings of a before-and-after study published in PLoS ONE in which Dr. Ahmed Balshi and colleagues at King Saud Medical City in Riyadh, Saudi Arabia, evaluated the impact of implementing remote patient monitoring with Masimo Patient SafetyNet on the efficacy of hospital rapid response teams (RRTs). Comparing outcomes before and after implementation of
Masimo to Present in 41st Annual J.P. Morgan Healthcare Conference 2023/01/04 21:05:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 10:30 a.m. Pacific Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide ar